Preclinical efficacy of immune-checkpoint monotherapy does not recapitulate corresponding biomarkers-based clinical predictions in glioblastoma. (Q38438763)
Jump to navigation
Jump to search
scientific article published on 03 March 2017
Language | Label | Description | Also known as |
---|---|---|---|
English | Preclinical efficacy of immune-checkpoint monotherapy does not recapitulate corresponding biomarkers-based clinical predictions in glioblastoma. |
scientific article published on 03 March 2017 |
Statements
Preclinical efficacy of immune-checkpoint monotherapy does not recapitulate corresponding biomarkers-based clinical predictions in glioblastoma (English)
Lien Vandenberk
Louis Boon
Matthias Van Woensel
Jochen Belmans
1 reference